Integris Health Secures Funding, Plans IPO by 2025

This move is part of Integris Health’s strategy to become a leading diversified medical devices company in India. Probir Das, appointed CEO in 2024, is set to lead these growth initiatives, with an IPO planned by the end of 2025.

Integris Health has secured primary capital from investors including Mukul Agarwal and India SME Fund. The funding will drive the company’s expansion into new therapeutic areas such as in-vitro diagnostics and laboratory solutions through strategic acquisitions and product development.

This move is part of Integris Health’s strategy to become a leading diversified medical devices company in India. Probir Das, appointed CEO in 2024, is set to lead these growth initiatives, with an IPO planned by the end of 2025.

Sharing thoughts, Avnish Mehra, Vice Chairman of Everstone Capital, said, “Integris Health’s growth trajectory reflects our commitment to building scalable healthcare platforms. This funding, combined with the company’s proven product development capabilities, consistent organic growth, and acquisition track record, reinforces its position as a transformative med-tech devices business serving hospitals and laboratories globally.”

Gurmit Singh Chugh, Co-Founder and Chairman of Integris Health, highlighted the industry's growth, saying, “The Indian med-tech devices industry is experiencing an unprecedented growth phase akin to the transformative opportunities witnessed by the Indian pharmaceutical sector in the early 2000s. Integris Health is poised to spearhead this global evolution, leveraging its cutting-edge R&D, strategic partnerships, robust distribution capabilities, and the cost-efficiency of Indian manufacturing.”

Probir Das, CEO, remarked, “The interest and support from prominent investors reflect the confidence in our vision to create India’s leading med-tech devices business. As we plan for our IPO, we remain committed to building Integris into a diversified business in this space. This market, particularly in developing economies, is poised for significant growth due to low penetration levels, and Integris is well-positioned to capitalize on this opportunity.”

Integris Health aims to strengthen its position as a global med-tech sector leader. The company's IPO preparations mark a significant step towards scaling operations and entering new markets.

Stay tuned for more such updates on Digital Health News.